Romero M I, Phelps C J
Neuroscience Training Program, Tulane University School of Medicine, New Orleans, Louisiana 70112.
Endocrinology. 1993 Oct;133(4):1860-70. doi: 10.1210/endo.133.4.8104778.
PRL-deficient dwarf mice exhibit marked reduction in dopamine (DA) and in tyrosine hydroxylase (TH) immunoreactivity in the PRL-regulating neurons of the hypothalamic arcuate nucleus (catecholaminergic area A12). Recent studies in this laboratory have revealed that this condition develops postnatally, in that A12 DA fails to increase and the number of TH-positive cells decreases after 21 days of age. The present study was designed to test whether PRL replacement during the early postnatal period would increase DA and TH expression in dwarfs. Ames dwarf (df/df) and normal sibling (DF/?) mice were treated with daily injections of ovine PRL (50 micrograms, ip) or vehicle for 30 days starting on postnatal day 12. Brains were evaluated by catecholamine histofluorescence and TH immunocytochemistry at the end of the treatment period. TH-positive cells were counted in A12 and medial zona incerta (area A13) and also differentially within A12, in dorsal and ventral regions, and at anterior, middle, and posterior levels. Histofluorescence and TH-positive cell number (P < 0.01) in vehicle-treated dwarfs were greatly reduced compared with those in DF/? mice in A12, but not in A13. However, A12 fluorescence in PRL-treated dwarfs was comparable to that in DF/? mice. TH cell counts in A12 of PRL-treated dwarfs were significantly higher (P < 0.01) than those in vehicle-treated dwarfs and not different from those in either group of DF/? mice. Within A12, both dorsal and ventral TH cell numbers were reduced in vehicle-treated dwarfs (P < 0.01); the reduction was greater in the ventral subpopulation (P < 0.01). TH cell counts were lower in middle and posterior (P < 0.05), but not anterior, areas of A12 in vehicle-treated df/df mice compared with those in DF/? mice. TH cell numbers in all A12 regions in PRL-treated dwarfs were not different from those in DF/? mice. Thus, PRL replacement initiated before 2 weeks of age in dwarfs is effective in supporting DA and TH expression in both A12 neurons and median eminence external zone at normal levels, providing direct evidence that the DA/TH deficit in dwarfs is secondary to endogenous PRL deficiency.
催乳素缺乏的侏儒小鼠在下丘脑弓状核(儿茶酚胺能A12区)的催乳素调节神经元中,多巴胺(DA)和酪氨酸羟化酶(TH)免疫反应性显著降低。本实验室最近的研究表明,这种情况在出生后才出现,即21日龄后A12区多巴胺未能增加,TH阳性细胞数量减少。本研究旨在测试出生后早期进行催乳素替代治疗是否会增加侏儒小鼠中多巴胺和TH的表达。从出生后第12天开始,对Ames侏儒(df/df)小鼠和正常同窝(DF/?)小鼠每天腹腔注射绵羊催乳素(50微克)或溶剂,持续30天。在治疗期结束时,通过儿茶酚胺组织荧光和TH免疫细胞化学对大脑进行评估。对A12区和内侧未定带(A13区)的TH阳性细胞进行计数,并在A12区内的背侧和腹侧区域以及前、中、后水平进行差异计数。与DF/?小鼠相比,溶剂处理的侏儒小鼠A12区的组织荧光和TH阳性细胞数量(P<0.01)大幅减少,但A13区没有。然而,催乳素处理的侏儒小鼠A12区的荧光与DF/?小鼠相当。催乳素处理的侏儒小鼠A12区的TH细胞计数显著高于(P<0.01)溶剂处理的侏儒小鼠,且与两组DF/?小鼠的计数无差异。在A12区内,溶剂处理的侏儒小鼠背侧和腹侧的TH细胞数量均减少(P<0.01);腹侧亚群的减少更为明显(P<0.01)。与DF/?小鼠相比,溶剂处理的df/df小鼠A12区中部和后部(P<0.05)而非前部的TH细胞计数较低。催乳素处理的侏儒小鼠A12区所有区域的TH细胞数量与DF/?小鼠无差异。因此,在侏儒小鼠2周龄前开始进行催乳素替代治疗可有效将A12神经元和正中隆起外侧区的多巴胺和TH表达维持在正常水平,直接证明了侏儒小鼠中多巴胺/TH缺乏是内源性催乳素缺乏的继发结果。